Lou Liguang | Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
スポンサーリンク
概要
関連著者
-
Lou Liguang
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
-
Li Jin
Department Of Medical Oncology Fudan University Shanghai Cancer Center
-
TIAN Shu
Department of Medical Oncology, Fudan University Shanghai Cancer Center
-
QUAN Haitian
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
-
XIE Chengying
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
-
GUO Haiyi
Department of Medical Oncology, Fudan University Shanghai Cancer Center
-
LU Fangfang
Department of Medical Oncology, Fudan University Shanghai Cancer Center
-
XU Yongping
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
-
Tian Shu
Department Of Medical Oncology Fudan University Shanghai Cancer Center
-
Guo Haiyi
Department Of Medical Oncology Fudan University Shanghai Cancer Center
-
Lu Fangfang
Department Of Medical Oncology Fudan University Shanghai Cancer Center
-
Xu Yongping
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
-
Quan Haitian
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
-
Xie Chengying
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
-
Li Jin
Department Of Medical Oncology Cancer Hospital Fudan University
-
Lou Liguang
Shanghai Institute Of Materia Medica Shanghai Institute For Biological Sciences Chinese Academy Of S
-
ZHAO Yunyu
Shanghai Institute of Materia Medica, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences
-
Zhao Yunyu
Shanghai Institute Of Materia Medica Shanghai Institute For Biological Sciences Chinese Academy Of Sciences
-
Li Jin
Department of Materials Science, Fudan University, 220 Handan road, Shanghai, 200433, P. R. China
著作論文
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- Differential Response of Akt to Cyclic AMP Modulates Drug Sensitivity(Molecular and Cell Biology)